Somatropin - Ferring Pharmaceuticals

Alternative Names: Tev-Tropin; TevTropin; ZOMACTON; Zomacton

Latest Information Update: 26 May 2022

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Savient Pharmaceuticals
Developer Elvetium; Ferring Pharmaceuticals; Teva Pharmaceuticals USA
Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
Mechanism of Action Human growth hormone replacements

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

24 May 2022 Antares Pharma has been acquired by Halozyme Therapeutics
06 Feb 2018 FDA approves somatropin for Somatotrophin deficiency (In adults) in USA (ADNM)
31 Jan 2018 Registered for Somatotropin deficiency (In adults) in USA (SC; 5mg, 10mg)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com